Roche to buy gene therapy specialist Spark in $4.3 billion deal

Roche on Monday said it will buy Spark Therapeutics in a transaction valued at $4.3 billion as the Swiss drugmaker builds its hemophilia portfolio and seeks to keep pace in gene therapy with rivals like Novartis.

from Reuters: Health News https://ift.tt/2BRgFQh
via IFTTT